Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marcucci

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Oncogene|August 8, 2017
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse modelL D'Abundo, E Callegari, A Bresin, et al.
Blood|June 8, 2012
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemiasNicholas A Zorko, Kelsie M Bernot, Susan P Whitman, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Cancer Research|January 13, 1998
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogeneticsM A Caligiuri, M P Strout, D Lawrence, et al.
Journal of Endocrinological Investigation|April 23, 2022
Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatmentG Marcucci, G Beccuti, G Carosi, et al.
Leukemia|March 3, 2012
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaS P Whitman, M A Caligiuri, K Maharry, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Leukemia|November 27, 2012
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemiaA Mims, A R Walker, X Huang, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Journal of Endocrinological Investigation|November 8, 2014
Rare diseases in clinical endocrinology: a taxonomic classification systemG Marcucci, L Cianferotti, P Beck-Peccoz, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Oncogene|August 8, 2017
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse modelL D'Abundo, E Callegari, A Bresin, et al.
Blood|June 8, 2012
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemiasNicholas A Zorko, Kelsie M Bernot, Susan P Whitman, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Cancer Research|January 13, 1998
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogeneticsM A Caligiuri, M P Strout, D Lawrence, et al.
Journal of Endocrinological Investigation|April 23, 2022
Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatmentG Marcucci, G Beccuti, G Carosi, et al.
Leukemia|March 3, 2012
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaS P Whitman, M A Caligiuri, K Maharry, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Leukemia|November 27, 2012
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemiaA Mims, A R Walker, X Huang, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Journal of Endocrinological Investigation|November 8, 2014
Rare diseases in clinical endocrinology: a taxonomic classification systemG Marcucci, L Cianferotti, P Beck-Peccoz, et al.
Pageof 11